Related Experiment Videos
[The search for anticancer agents at IDR]
1Gyógyszerkutató Intézet, Kft. 1325-Budapest, Pf 82.
Abstract:
This paper deals with results of the search for anticancer agents achieved at IDR during the period of 1953-1983. This research activity concentrated on the following four topics: 1) biological alkylating agents, 2) nucleoside type antimetabolites, 3) anthracyclin antibiotics and 4) analogs of tamoxifen. Among those the first one was the most successful, resulting in five new cytostatics, which were marketed under the tradename Degranol [1,6-bis-(2-chloroethylamino)-1,6-dideoxy-D-mannitol], Mannogranol [1,6-dibromo-1,6-dideoxy-D-mannitol], Myelobromol [1,6-dibromo-1,6-dideoxy-galactitol], Zytostop [1,2,5,6-tetra-O-methanesulfonyl-D-mannitol] and Lycurim [1,4-bis-(mesyloxiethylamino)-1,4-dideoxy-eryhtritol].
Insights
Researchers at IDR successfully developed five new cytostatics, primarily through exploring biological alkylating agents. These anticancer agents, including Degranol and Mannogranol, represent significant advancements in cancer treatment.
Area of Science:
- Oncology
- Medicinal Chemistry
- Pharmacology
Context:
- The development of novel anticancer agents is crucial for improving patient outcomes.
- The period between 1953 and 1983 saw intensive research into various classes of chemotherapeutic compounds.
Purpose:
- To document the outcomes of anticancer agent research conducted at IDR from 1953 to 1983.
- To highlight the most successful research areas and resulting drug candidates.
Summary:
- Research focused on four main areas: biological alkylating agents, nucleoside antimetabolites, anthracycline antibiotics, and tamoxifen analogs.
- Biological alkylating agents proved most fruitful, leading to the discovery and marketing of five cytostatic drugs.
- Marketed cytostatics include Degranol, Mannogranol, Myelobromol, Zytostop, and Lycurim, with their chemical structures noted.
Impact:
- The successful development of these cytostatics contributed significantly to the armamentarium against cancer during the study period.
- This research laid the groundwork for future anticancer drug discovery and development.
- The commercialization of these agents provided new therapeutic options for cancer patients.